The DOI matches its Crossref record.
Ovarian cancer: Survival and treatment differences by age
Open accessAbstract
BACKGROUND: Cancer of the ovary is a disease of older American women with an incidence rate of 9.4 per 100,000 for those under 65 compared to 54.8 per 100,000 for those 65 years of age and over. METHODS: Over 22,000 women were diagnosed with ovarian cancer between 1973 and 1987 within the Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute. SEER is a population-based program that covers nearly 10% of the U.S. population for cancer incidence and survival. RESULTS: Ovarian cancer survival rates vary dramatically by stage. Within stage, however, differences are noted in survival by age, with younger women surviving better than older women even after adjustment for the general life expectancy of each age group (relative survival). For Stages III-IV disease, women under 45 years of age have a 5-year relative survival rate of over 45% compared to only 8% for those 85 years of age and over. Between 1973-1977 and 1983-1987, the treatment for Stages III-IV disease has changed. For all age groups, there were sharp increases in the percentage having surgery and chemotherapy/hormonal therapy and decreases in those having surgery and radiation as part of the first course of therapy. Over 40% of women 85 years of age and over did not receive any definitive treatment according to the hospital medical record. In 1983-1987, younger women received more combination therapy (surgery with chemotherapy/hormonal therapy) versus older women who received more single modalities such as surgery only or chemotherapy/hormonal therapy only. CONCLUSIONS: Older women with ovarian cancer are treated less aggressively than their younger counterparts and have poorer survival rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 4
- 1991, Cancer statistics review 1973-88
- Yancik, 1993, Ovarian cancer: age contrasts in incidence, histology, stage at diagnosis, and mortality, Cancer, 71, 517, 10.1002/cncr.2820710205 · DOI · Paper page
- Ederer, 1961, The relative survival rate: a statistical methodology, Natl Cancer Inst Monogr, 6, 101
- Yancik, 1986, Ovarian cancer in the elderly: an analysis of surveillance, epidemiology, and end results program data, Am J Obstet Gynecol, 154, 639, 10.1016/0002-9378(86)90623-X · doi:10.1016/0002-9378(86)90623-x
Cited by
Ovarian cancer in the world: epidemiology and risk factors
Momenimovahed, Z., Tiznobaik, A., Taheri, S., & Salehiniya, H. (2019) · International Journal of Women's Health · doi:10.2147/ijwh.s197604 · Cited by 912
Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
Winter, W. E., Maxwell, G. L., Tian, C., Carlson, J. W., Ozols, R. F., Rose, P. G., Markman, M., Armstrong, D. K., Muggia, F., & McGuire, W. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2517 · Cited by 845
Associations of social networks with cancer mortality: a meta-analysis
Pinquart, M., & Duberstein, P. R. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.06.003 · Cited by 460
Kosary, C. L. (1994) · Seminars in Surgical Oncology · doi:10.1002/ssu.2980100107 · Cited by 417
Ovarian cancer: Age contrasts in incidence, histology, disease stage at diagnosis, and mortality
Yancik, R. (2010) · Cancer · doi:10.1002/cncr.2820710205 · Cited by 309
Metadata
- Authors
- Ries, L. A. G.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2010-08-31
- Volume
- 71
- Issue
- S2
- Pages
- 524-529
- ISSN
- 0008-543X (ISSN-L)
- OpenAlex
- W1994964315
- Cited by
- 165
- References
- 0
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1827 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ovarian cancer: Survival and treatment differences by age. https://app.cochat.ai/papers/10.1002/cncr.2820710206
- The paper
- Ries, L. A. G. (2010). Ovarian cancer: Survival and treatment differences by age. Cancer. https://doi.org/10.1002/cncr.2820710206
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.